UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017892
Receipt number R000020729
Scientific Title The effectiveness of Maoto suppository for infants
Date of disclosure of the study information 2015/07/01
Last modified on 2015/06/12 18:45:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effectiveness of Maoto suppository for infants

Acronym

Effectiveness of Maoto suppository

Scientific Title

The effectiveness of Maoto suppository for infants

Scientific Title:Acronym

Effectiveness of Maoto suppository

Region

Japan


Condition

Condition

Cold

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We study the effectiveness of Maoto suppository for infants who have acute disease like fever.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

assess the fever period and improvement of the symptoms

Key secondary outcomes

Clinical findings (considering to age, gender, height, body weight,so on)
Laboratory findings (white blood cell, C-reactive protein)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Duration: 6 months
Quantity: 0.5 g
Time: once
The name of the drug: Tsumura Maoto Ekisu Karyu

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 months-old <

Age-upper limit

72 months-old >=

Gender

Male and Female

Key inclusion criteria

the patients who come to our hospital whose age are under 6 years old.
the fever's duration should be under 3 days.

Key exclusion criteria

1) doctor can exclude the patients if they are not appropriate for this study
2) the patients who have underlying diseases like cardiac or kidney diseases
3) the patients who take other Kampo medicines before

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name watanabe toru

Organization

Hamamatsu Rosai Hospital

Division name

Pediatrics

Zip code


Address

Hamamatsu City Higashi Distric Shogencho 25

TEL

053-462-1211

Email

brightsirius@msn.com


Public contact

Name of contact person

1st name
Middle name
Last name watanabe toru

Organization

Hamamatsu Rosai Hospital

Division name

Pediatrics

Zip code


Address

Hamamatsu City Higashi District Shogencho 25

TEL

053-462-1211

Homepage URL

http://www.hamamatsuh.rofuku.go.jp/

Email

brightsirius@msn.com


Sponsor or person

Institute

Hamamatsu Rosai Hospital

Institute

Department

Personal name



Funding Source

Organization

Hamamatsu Rosai Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 07 Month 01 Day


Related information

URL releasing protocol

http://www.hamamatsuh.rofuku.go.jp/

Publication of results

Unpublished


Result

URL related to results and publications

http://www.hamamatsuh.rofuku.go.jp/

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2015 Year 06 Month 12 Day

Date of IRB


Anticipated trial start date

2015 Year 07 Month 01 Day

Last follow-up date

2015 Year 12 Month 31 Day

Date of closure to data entry

2015 Year 12 Month 31 Day

Date trial data considered complete

2015 Year 12 Month 31 Day

Date analysis concluded

2015 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 06 Month 12 Day

Last modified on

2015 Year 06 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020729


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name